About Blaise Coleman
Blaise Coleman is a director at Ocugen.
Form D filings name Blaise Coleman as a president; chief executive officer and director at Endo.
Blaise Coleman reports to the SEC as a director or officer of 2 public companies, including Endo International plc (ENDP).
Blaise Coleman first appears on SEC filings in 2016.
Experience
This experience comes from SEC filings. The years are when the filings name Blaise Coleman in the role, so the role may have started earlier or lasted longer.
OI
Ocugen, Inc.
Director
2025 – 2026 · Public company (OCGN)
EP
Endo International plc
President, CEO and director
2016 – 2022 · Public company (ENDP)
Key Colleagues at Startups
The people Blaise Coleman works with at each company, as listed on that company's latest Form D.
Endo, Inc. · Form D/A, May 6, 2024
SH
Scott Hirsch
Director
PE
Paul Efron
Director
PH
Paul Herendeen
Director
MY
Marc Yoskowitz
Director
PB
Patrick Barry
Executive Vice President; President, Global Commercial Operations
MM
Matthew Maletta
Executive Vice President; Chief Legal Officer; Secretary
SL
Sophia Langlois
Director
FR
Frank Raciti
Vice President; Controller; Chief Accounting Officer
MB
Mark Bradley
Executive Vice President; Chief Financial Officer and director
AP
Andy Pasternak
Director